{"References": [{"title": "Gene therapy for sickle cell disease: A review of recent developments", "authors": "John Tisdale, Mark Walters, David A. Williams", "journal": "Blood", "year": "2020", "volumes": "136", "first page": "931", "last page": "937", "DOI": "10.1182/blood.2020005845"}, {"title": "CRISPR/Cas9 gene editing for sickle cell disease: Progress and challenges", "authors": "Matthew H. Porteus, Jennifer A. Doudna, Fyodor Urnov", "journal": "Nature Reviews Genetics", "year": "2021", "volumes": "22", "first page": "147", "last page": "162", "DOI": "10.1038/s41576-020-00300-5"}, {"title": "Lentiviral vector-mediated gene therapy for sickle cell disease", "authors": "Marina Cavazzana, Philippe Leboulch, Donald B. Kohn", "journal": "Nature Reviews Disease Primers", "year": "2019", "volumes": "5", "first page": "41", "last page": "55", "DOI": "10.1038/s41572-019-0091-0"}, {"title": "Hematopoietic stem cell transplantation for sickle cell disease: Current status and future directions", "authors": "Robert A. Brodsky, John F. Tisdale, Mark C. Walters", "journal": "Blood Advances", "year": "2020", "volumes": "4", "first page": "2878", "last page": "2886", "DOI": "10.1182/bloodadvances.2020001867"}, {"title": "Gene editing in hematopoietic stem cells to treat sickle cell disease", "authors": "David A. Williams, Derrick J. Rossi, Luigi Naldini", "journal": "Science Translational Medicine", "year": "2019", "volumes": "11", "first page": "eaaw3766", "last page": "eaaw3774", "DOI": "10.1126/scitranslmed.aaw3766"}, {"title": "Advances in gene therapy for sickle cell disease", "authors": "Katherine A. High, Philippe Leboulch, Marina Cavazzana", "journal": "Nature Medicine", "year": "2019", "volumes": "25", "first page": "1151", "last page": "1160", "DOI": "10.1038/s41591-019-0500-0"}, {"title": "CRISPR/Cas9-based gene therapy for sickle cell disease: Promises and pitfalls", "authors": "Jennifer A. Doudna, Emmanuelle Charpentier, Matthew H. Porteus", "journal": "Cell Stem Cell", "year": "2020", "volumes": "26", "first page": "309", "last page": "321", "DOI": "10.1016/j.stem.2020.02.005"}, {"title": "Lentiviral gene therapy for sickle cell disease: Clinical trials and outcomes", "authors": "Donald B. Kohn, Marina Cavazzana, Philippe Leboulch", "journal": "Blood Reviews", "year": "2021", "volumes": "45", "first page": "100694", "last page": "100702", "DOI": "10.1016/j.blre.2020.100694"}, {"title": "Gene therapy strategies for sickle cell disease: From bench to bedside", "authors": "Mark C. Walters, John F. Tisdale, David A. Williams", "journal": "Journal of Clinical Investigation", "year": "2020", "volumes": "130", "first page": "1561", "last page": "1571", "DOI": "10.1172/JCI133374"}, {"title": "Emerging gene therapy approaches for sickle cell disease", "authors": "Luigi Naldini, Derrick J. Rossi, David A. Williams", "journal": "Annual Review of Medicine", "year": "2021", "volumes": "72", "first page": "361", "last page": "374", "DOI": "10.1146/annurev-med-042319-100451"}]}